Effepharm , the first NMN raw material manufacturer to do clinical trials
Clinical trials drive innovation and progress
High-end brand raw material supplier
Strong brand competitiveness
Great market share
We are always on the road
In September We were invited to the China-Australia Clinical Research Executive Summit as the only food ingredient company. All the other attendees were from pharmaceutical companies.
With an all-star R&D team, whose members came from top pharmaceutical companies like GSK in the US and international organizations like USP, we know the difference between dietary food and normal food. And we’re proud to be the first ingredient manufacturer to conduct the clinical trial on our Uthever NMN ingredient.
Our clinical study would include:
(1) Safety assessment
(3) Boosting energy
Prior to this clinical study, we would also conduct preclinical study, which would include:
(1) Acute toxicity study
(2) 90-day subchronic oral study
(3) Bacterial mutagenesis-Ames
(4) In vitro cytogenetics-Chromosome aberration test in CHO cell lines
(5) In vivo mammalian test-Chromosome aberration test in Mouse
Effepharm is committed to conducting rigorous research and will share them with our customers and the public.